Business Model ProQr


About ProQr

Changing lives is what drives us at ProQR. With a highly energetic team of professionals we strive to make a meaningful impact on the lives of patients and the people around them. By combining innovative technologies and entrepreneurism, we aim to develop novel RNA treatments to transform the lives of patients suffering from severe genetic disorders.
ProQR was born from the dream to beat cystic fibrosis, our drug candidate QR-010 is now being tested in CF patients in clinical trials. But we won’t stop there. We have built a broad pipeline with programs that targets other severe disorders such as Leber’s congenital amaurosis, the most common cause of childhood blindness, for which we will soon initiate clinical development.
We believe all patients should be allowed to dream about the future. That is what makes us passionate and impatient. We dare to do things differently and challenge the status quo, all in the interest of patients. When you’re as driven to make a meaningful impact as we are, this can only be the start of something big.

Daniel de Boer

Daniel de Boer

Daniel de Boer is our founding Chief Executive Officer since our incorporation in 2012. Daniel is a passionate and driven entrepreneur and advocate for CF patients, and has assembled an experienced team of successful biotech executives as co-founders and early investors. As a serial entrepreneur in IT, he founded and led a number of tech companies through phases of growth, initiating development and launch of several IT related products in several European countries. Prior to founding ProQR, Daniel served as a founder and Chief Executive Officer of RNA Systems, founder and Chief Executive Officer of PC Basic, and founder and Chief Executive Officer of Running IT. At ProQR Daniel is responsible for the overall strategy and general business.

Jumpstart your career

Join BioBusiness Summer School to jumpstart your career in Life Sciences by gaining knowledge of business aspects such as product development, IPR, finance and business models. The next edition of the summer school will be organised from 24-28 June 2019 in Amsterdam, the Netherlands.

Why participate

The BioBusiness Summer School is a programme tailored to bridge the gap. By immersing yourself in the business aspects of Life Sciences during this programme, you will learn the basic knowledge of BioBusiness, gain insight in the world of Life Sciences companies, meet leading business leaders and increase your international network.

Employers meet talent

Is your organisation interested in early-career talents in Life Sciences? BioBusiness Summer School can get you in touch with business oriented PhDs, postdocs or Master students. More info can be found here.